Daniel N Kazdal

31PUBLICATIONS
96CO-AUTHORS
Molecular targetsCancer geneticsCancer diagnosisGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Apr 11, 2026
Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy.

Jana Samarin, Hana Nůsková, Piotr Fabrowski

|Apr 07, 2026
Implementing whole genome and transcriptome sequencing for cancer patients in routine healthcare: a comprehensive guide to costing.

Christian Altbürger, Michael Menzel, Susanne Beck

|Mar 02, 2026
Correction: Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samples.

Markus Ball, Susanne Beck, Darius Wlochowitz

|Jan 13, 2026
Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samples.

Markus Ball, Susanne Beck, Darius Wlochowitz

|Aug 06, 2025
Impact of Baseline β-Catenin Comutations on Prognosis in EGFR-Mutant Lung Cancer.

Jonas Kulhavy, Katja Maurus, Miriam Blasi

|Jul 29, 2025
CG>TG mutation frequency as negative predictor of homologous recombination deficiency in ovarian and breast cancer.

Eva Romanovsky, Michael Menzel, Klaus Kluck

Pageof 6